The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence

The Ultimaster coronary stent system (Terumo Corporation, Tokyo, Japan) represents a new iteration in drug-eluting stent (DES) technology that has recently received the Conformité Européenne (CE) mark approval for clinical use. The Ultimaster is a thin-strut, cobalt chromium, biodegradable-polymer,...

Full description

Bibliographic Details
Main Authors:	Alberto Chisari, Anna Maria Pistritto, Raffaele Piccolo, Alessio La Manna, Gian Battista Danzi
Format:	Article
Language:	English
Published:	MDPI AG 2016-09-01
Series:	International Journal of Molecular Sciences
Subjects:	Ultimaster stent biodegradable polymer drug eluting stent new-generation DES sirolimus-eluting stent coronary stent
Online Access:	http://www.mdpi.com/1422-0067/17/9/1490

Similar Items

A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01)

Clinical performance of biodegradable polymer coated Sirolimus-eluting stent in multivessel disease: Results from MULTIDES study
by: Anurag Polavarapu, et al.
Published: (2016-01-01)

Drug-eluting stents: long-term safety
by: Yu A Karpov, et al.
Published: (2009-05-01)

Very late stent thrombosis of Sirolimus-eluting stent 59 months after implantation: A first report from the Middle-East and review of literature
by: Prashanth Panduranga, et al.
Published: (2011-01-01)

Erosion/malapposition of a sirolimus eluting stent – Optical coherence tomography image – A case report
by: G. Sengottuvelu
Published: (2012-11-01)

In vivo assessment of stent recoil of biodegradable polymer-coated cobalt–chromium sirolimus-eluting coronary stent system
by: Atul D. Abhyankar, et al.
Published: (2012-11-01)

Improved vascular healing after the successful treatment of very late sirolimus-eluting stent thrombosis with a bare metal stent implantation – A serial optical coherence tomography study
by: Konstantina P. Bouki, MD, et al.
Published: (2016-03-01)

Comparison of sirolimus-eluting stent versus polyzene-F polymer-coated stent in terms of early inflammatory response and long term outcomes
by: Murat Yuksel, et al.
Published: (2015-06-01)

Real-World Use Of Ultrathin-Strut Biodegradable Polymer–Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes
by: Ajmera P, et al.
Published: (2019-10-01)

Interim Results of the Basket of Real-World Randomised Clinical PRISM Trials for M’Sure-S, a Next-Generation Sirolimus-Eluting Stent, Versus Eliminator, an Everolimus-Eluting Stent
by: Marc Silvestri, et al.
Published: (2018-09-01)

Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01)

Ten-year survival of patients undergoing coronary angioplasty with first-generation sirolimus-eluting stents and bare-metal stents
by: Nelson Vale, et al.
Published: (2020-11-01)

The Twelve-Month Outcome of Biolimus Eluting Stent with Biodegradable Polymer Compared With an Everolimus Eluting Stent with Durable Polymer
by: Ahmad Separham, et al.
Published: (2011-11-01)

Biodegradable Stent with mTOR Inhibitor-Eluting Reduces Progression of Ureteral Stricture
by: Dong-Ru Ho, et al.
Published: (2021-05-01)

Clinical outcomes and complications of treatment with supraflex stent in patients with coronary artery disease: One year follow up
by: Zahra Sharifi, et al.
Published: (2019-05-01)

Optimized sirolimus-eluting stent by coating asymmetrically with biodegradable and cytocompatible polymers
by: Seong Min Kim, et al.
Published: (2016-02-01)

Reestenose tardia associada à fratura de stent Cypher Reestenosis tardía asociada a fractura de stent Cypher Late restenosis related to Cypher stent fracture
by: Michel Pereira Cadore, et al.
Published: (2009-11-01)

One-year outcomes of a BioMime™ Sirolimus-Eluting Coronary Stent System with a biodegradable polymer in all-comers coronary artery disease patients: The meriT-3 study
by: Rajendra Kumar Jain, et al.
Published: (2016-09-01)

A first-in-man study of sirolimus-eluting, biodegradable polymer coated cobalt chromium stent in real life patients
by: Ashok Seth, et al.
Published: (2012-11-01)

Twelve-month clinical outcomes of sirolimus-eluting stent in coronary artery disease: An experience in real-world Indian patients
by: Srikanth Nathani, et al.
Published: (2020-11-01)

Safety and efficacy of biodegradable polymer-coated biolimus-eluting stents
by: Walid Maamoun
Published: (2013-09-01)

A prospective study evaluating efficacy of polymer free Pronova XR stent in treatment of denovo coronary artery stenosis
by: N.V. Deshpande, et al.
Published: (2014-01-01)

Drug-eluting metallic stents in urology
by: Panagiotis S Kallidonis, et al.
Published: (2014-01-01)

Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis
by: Leos Pleva, et al.
Published: (2017-06-01)

Biodegradable polymer drug-eluting stents versus second-generation drug-eluting stents in patients with and without diabetes mellitus: a single-center study
by: Xiao-Fang Tang, et al.
Published: (2018-08-01)

A prospective, multicenter, post marketing surveillance study to evaluate the safety and effectiveness of the Superia-Sirolimus Eluting Coronary Stent System (SSECSS) implanted during routine clinical practice in India
by: Praveen Chandra, et al.
Published: (2014-11-01)

Endovascular Treatment with Limus Eluting Stents in Patients with Acute Coronary Syndrome
by: M. V. Chernyayev, et al.
Published: (2019-04-01)

Ureteral stent technology: Drug-eluting stents and stent coatings
by: Luo Yang, et al.
Published: (2015-10-01)

EFFICACY OF SIROLIMUS ELUTING STENTS IMPLANTATION IN DIFFUSE (LONG AND EXTREMELY LONG) CORONARY ATHEROSCLEROTIC LESIONS
by: A. M. Babunashvili, et al.
Published: (2017-10-01)

Evaluation of Clinical Outcomes in Patients Undergoing Dual Vessel Percutaneous Coronary Intervention Using Sirolimus-Eluting Coronary Stent System in India
by: Prakash Chandwani, et al.
Published: (2015-02-01)

Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)

Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting
by: Damian Maciejewski, et al.
Published: (2019-09-01)

Twelve-months clinical outcomes of biodegradable polymer-coated sirolimus-eluting coronary stent in real-world patients: A single-center experience.
by: Pankaj Jariwala, MD, DNB, DNB, MNAMS, FICPS, FACC, FSCAI, Fellowship in Interventional Cardiology (ICPS, Paris, France), et al.
Published: (2021-01-01)

Long-term results of coronary endovascular revascularisation with eluting sirolimus-stents in patients with coronary heart disease comorbid with type-2 diabetes mellitus: evidence from 18-month prospective study
by: A T Teplyakov, et al.
Published: (2009-05-01)

Drug-Eluting Balloon versus New-Generation Drug-Eluting Stent for the Treatment of In-Stent Restenosis: An Updated Systematic Review and Meta-Analysis
by: Kong-Yong Cui, et al.
Published: (2018-01-01)

Five-Year Comparative Efficacy of Everolimus-Eluting vs. Resolute Zotarolimus-Eluting Stents in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Endrin Koni, et al.
Published: (2021-03-01)

High nitrogen stainless steel drug-eluting stent - Assessment of pharmacokinetics and preclinical safety in vivo
by: Shanshan Chen, et al.
Published: (2020-12-01)

Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study
by: Chih-Yuan Fang, et al.
Published: (2018-04-01)

Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01)

Late neointimal volume reduction is observed following biodegradable polymer-based drug eluting stent in porcine model
by: Takeshi Ijichi, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_tis7946hhbigei2odgvlnvk5us